300841.SZ
康华生物
SZSE · Healthcare · C 制造业 · CN
CNY 53.27
−5.72%Margins
Gross margin
91.6%
EBITDA margin
29.0%
EBIT margin
22.5%
Net margin
18.9%
FCF margin
30.0%
6.4%
Return on equity
5.8%
Return on assets
7.5%
Return on invested capital
0.30x
Asset turnover
CNY 417.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026